D V Unverferth - Concepedia

Author

D V Unverferth

Unilever (United Kingdom)

Also Known As

D V Unverferth, D. V UNVERFERTH, Donald V. Unverferth, Unverferth, Donald V.

Publications

725

Citations

H-Index

Concepts

All Affiliations

Unilever (United Kingdom)The Ohio State University Laboratoire d’Électronique, Informatique et Image

About

D V Unverferth is an author at Unilever (United Kingdom) specializing in medicine, cardiovascular disease, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	569
2	Health Sciences	3	3	321
3	Public Health	3	3	248
4	Applied Physiology	2	2	150
5	Anesthesia	1	1	48

D V Unverferth

Publications

721

Citations

H-Index

Page 1

	Year	Citations
Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Mark E. Leithe, R D Margorien, James Hermiller, Circulation HypertensionHeart FailureHemodynamicsCentral HemodynamicsCardiovascular Function	1984	171
Drug-induced conditioning in congestive heart failure. Carl V. Leier, Patricia Huss, Richard P. Lewis, Circulation Heart FailureCardiovascular DiseaseExercise PhysiologyCardiovascular PharmacologyDrug-induced Conditioning	1982	112
Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. Harry L. Graber, D V Unverferth, Peter B. Baker, Circulation Family MedicineCardiac MuscleHeart FailureFamily MembersPathology	1986	106
Captopril in primary pulmonary hypertension. C V Leier, D Bambach, Sarah E. Nelson, Circulation HypertensionPulmonary HypertensionPharmacotherapyPrimary Pulmonary HypertensionExercise	1983	102
Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study. D V Unverferth, C V Leier, Raymond D. Magorien, Journal of Pharmacology and Experimental Therapeutics	1980	53
Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning. Michael Sullivan, Philip F. Binkley, D V Unverferth, Journal of Clinical Investigation Physical ActivityPharmacotherapySynthetic CatecholKinesiologyExercise	1985	48
Serum and Tissue Magnesium Concentrations in Patients with Heart Failure and Serious Ventricular Arrhythmias Michael Ralston, M R Murnane, D V Unverferth, Annals of Internal Medicine	1990	32
Attempt to Prevent Doxorubicin-Induced Acute Human Myocardial Morphologic Damage With Acetylcysteine<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref> D V Unverferth, J.M. Jagadeesh, B J Unverferth, JNCI Journal of the National Cancer Institute Cardiovascular PharmacologyPathologyPharmacotherapyCardiovascular ToxicityCardiovascular Translational Research	1983	30
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. James Hermiller, Mark E. Leithe, Raymond D. Magorien, Journal of Pharmacology and Experimental Therapeutics	1984	30
The evolution of -adrenergic dysfunction during the induction of canine cobalt cardiomyopathy D V Unverferth, Richard H. Fertel, Jackson Thomas, Cardiovascular Research	1984	23

Page 1